Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Myocardial infarct: acute intervention]

H A Katus1, T Scheffold, C Bode

  • 1Medizinische Universitätsklinik, Innere Medizin III, Kardiologie, Angiologie, Pulmonologie, Heidelberg.

Zeitschrift Fur Kardiologie
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usability and feasibility of E-nergEYEze: a blended vision-specific E-health based cognitive behavioral therapy and self-management intervention to reduce fatigue in adults with visual impairment.

BMC health services research·2023
Same author

Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.

West African journal of medicine·2023
Same author

The effectiveness of motivational interviewing on adherence to wearing orthopedic shoes in people with diabetes at low-to-high risk of foot ulceration: A multicenter cluster-randomized controlled trial.

Diabetes research and clinical practice·2023
Same author

Attitudes and experiences towards the application of motivational interviewing by podiatrists working with people with diabetes at high-risk of developing foot ulcers: a mixed-methods study.

Journal of foot and ankle research·2022
Same author

Using motivational interviewing combined with digital shoe-fitting to improve adherence to wearing orthopedic shoes in people with diabetes at risk of foot ulceration: study protocol for a cluster-randomized controlled trial.

Trials·2021
Same author

Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.

Purinergic signalling·2021
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016
Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016
Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016
Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016
See all related articles

Early reperfusion therapy, including thrombolytics or primary angioplasty, significantly reduces mortality in acute myocardial infarction, especially for high-risk patients. Timely treatment is crucial for limiting infarct size and improving outcomes.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Context:

  • Acute myocardial infarction (AMI) management focuses on limiting infarct size and complications.
  • Early reperfusion of ischemic myocardium is key to achieving treatment goals.

Purpose:

  • To review current treatment strategies for acute myocardial infarction.
  • To evaluate the efficacy of reperfusion therapies and adjunctive treatments.

Summary:

  • Thrombolytic agents (streptokinase, APSAC, rtPA) significantly reduce mortality in AMI, with greatest benefit in high-risk individuals.
  • Primary percutaneous coronary intervention (PTCA) is a viable alternative, particularly in anterior wall MI or cardiogenic shock.
  • Adjunctive therapies like heparin and newer antithrombotics show promise in preventing reocclusion. Certain conservative treatments (aspirin, beta-blockers, nitrates, magnesium) reduce mortality, while ACE inhibitors are beneficial if given later.

Related Experiment Videos

Impact:

  • Early reperfusion therapy improves survival rates and preserves left ventricular function in AMI patients.
  • Identifying optimal timing and combinations of therapies can further enhance patient outcomes.
  • Ongoing research into novel antithrombotic agents aims to minimize reocclusion and improve long-term prognosis.